With you beside us, our researchers are advancing cancer cures and making treatments safer, less difficult, and more effective.
Clinical Research and Vaccine and Infectious Disease Divisions
Fighting deadly infections
Dr. Josh Hill examines the causes of life-threatening infections in patients with compromised immune systems. By developing powerful new therapies to prevent and treat these infections, he is increasing survival and improving quality of life for transplant patients.
Human Biology and Clinical Research Divisions
Tackling difficult cancers
Dr. Andrew Hsieh is deciphering how cancer cells tick and finding therapies for understudied and hard-to-treat cancers. His work on bladder cancer, for example, is yielding new insights into the inner workings of a devastating disease that has long eluded researchers.
Public Health Sciences Division
Helping where it hurts
Cancer treatments save lives, but they can be very hard on patients. Dr. Salene Jones is looking closely at the personal and environmental factors that affect people’s quality of life as they face cancer. Her goal? Therapeutic approaches that treat the whole person by reducing anxiety and depression during treatment.
Clinical Research Division
Personalizing leukemia treatment
Dr. Jerry Radich’s focus is on creating new tools to improve the diagnosis and treatment of two types of blood cancer: chronic and acute myeloid leukemia. Currently, he is developing a test that analyzes a patient's leukemia cells to identify their best treatment options and predict their risk of relapse, giving clinicians new ways to improve and customize care.
Vaccine and Infectious Disease Division
Combatting cancer globally
By studying the estimated one-fifth of cancers linked to viruses and other pathogens, Deputy Head of Global Oncology Dr. Thomas Uldrick is improving care for people worldwide. For example, he is currently studying why people living with HIV have a higher risk of lung cancer — potentially helping clinicians and patients intercept cancer before it starts.
Seattle Translational Tumor Research (STTR)
Ganging up on tumors
We need cures now
— so why work alone? Scientists from Fred Hutch, the University of Washington, and the Seattle Cancer Care Alliance are teaming up to save lives. Through the Seattle Translational Tumor Research group, top experts are pooling information on the most effective treatments for tumors, sharing research, and mining huge data sets to turn discoveries into therapies as quickly as possible.